A randomised controlled trial in HIV positive patients comparing the efficacy of lopinavir/ritonavir monotherapy versus conventional triple therapy.

Trial Profile

A randomised controlled trial in HIV positive patients comparing the efficacy of lopinavir/ritonavir monotherapy versus conventional triple therapy.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2012

At a glance

  • Drugs Antiretrovirals; Lopinavir/ritonavir
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms MAIMOKA
  • Most Recent Events

    • 12 May 2012 Netherlands Trial Register reports trial status as unconfimed, additional trial centre, investigator (Agtmael, van), identifier (1732) identified.
    • 08 May 2012 Official Title amended as reported by ClinicalTrials.gov.
    • 08 May 2012 New source identified and integrated (Netherlands Trial Register; NTR436).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top